The survival rate within 5 years of taking bicalutamide for advanced prostate cancer can reach about 70%~80%, but it depends on the development of the disease and the control effect. Bicalutamide is a kind of drug that can resist androgen, can promote luteinization and release hormone, the treatment effect for advanced prostate cancer patients is relatively clear, through timely treatment, the survival rate of patients within 5 years can reach about 40%~50%. However, if the prostate cancer patient reaches the advanced stage, the condition is more serious, and the symptoms are relatively obvious, the tumor grows faster, and the survival rate within 5 years is relatively low, which may be only about 10%~20%, then this situation needs to be combined with other medications, such as Goserelin, Leucovorin, etc., in addition to taking Bicalutamide. If the effect of taking bicalutamide in advanced stage of prostate cancer is relatively clear, you need to insist on taking it and go to the hospital for regular review to know the metastasis of the cancer cells as well as the spread of the cancer cells, so as not to be negligent and careless, so as not to make a mistake in the condition.